Literature DB >> 15921796

Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit.

Valerio Verdiani1, Carlo Nozzoli, Francesca Bacci, Adriana Cecchin, Maria Serena Rutili, Sergio Paladini, Iacopo Olivotto.   

Abstract

BACKGROUND: B-type natriuretic peptide (BNP) represents a promising predictor of early (30 days) re-admission in patients with heart failure (HF) admitted to cardiology units. Whether BNP retains its predictive value in unselected patients admitted to general medical wards is unknown.
METHODS: We determined BNP levels on admission and pre-discharge in 100 consecutive patients (71 male, mean age 78+/-10 years) admitted to a general medical unit due to decompensated HF. Follow-up after discharge was 30 days.
RESULTS: Of the 100 patients, 86 had >/=1 comorbid conditions. Median BNP was 739 pg/ml on admission (25th-75th percentile 355-1333 pg/ml, respectively), and 414 pg/ml pre-discharge (25th-75th percentile 220-696 pg/ml). Seventeen patients were re-admitted or died within 30 days. Patients with pre-discharge BNP values >75th percentile (696 pg/ml) had greater risk of re-hospitalisation, as compared to values </=696 pg/ml (56% vs. 4%, respectively; p<0.001). Negative predictive value for this cut-off was 96%. BNP values >75th percentile were associated with a 15.0 independent relative hazard (RH) of early re-admission or death (95% CI 4.2-53.8; p<0.0001). The other independent predictor was a NYHA class >/=III at discharge (RH 2.9; 95% CI 1.1-9.3; p<0.05).
CONCLUSION: In a general medical unit, pre-discharge BNP levels were a strong independent predictor of early re-admission or death due to HF, irrespective of substantial comorbidity and advanced age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921796     DOI: 10.1016/j.ejheart.2004.12.006

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  10 in total

1.  Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.

Authors:  Hidenori Moriyama; Takashi Kohno; Shun Kohsaka; Yasuyuki Shiraishi; Ryoma Fukuoka; Yuji Nagatomo; Ayumi Goda; Atsushi Mizuno; Keiichi Fukuda; Tsutomu Yoshikawa
Journal:  Heart Vessels       Date:  2019-05-27       Impact factor: 2.037

Review 2.  Natriuretic peptides in the diagnosis and management of heart failure.

Authors:  G Michael Felker; John W Petersen; Daniel B Mark
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

3.  Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

Authors:  Robb D Kociol; John R Horton; Gregg C Fonarow; Eric M Reyes; Linda K Shaw; Christopher M O'Connor; G Michael Felker; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2011-07-08       Impact factor: 8.790

4.  Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

Authors:  A Jan; N F Murphy; C O'Loughlin; M Ledwidge; K McDonald
Journal:  Ir J Med Sci       Date:  2011-03-03       Impact factor: 1.568

Review 5.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 6.  Heart failure biomarkers.

Authors:  Rajiv Choudhary; Navaid Iqbal; Fatima Khusro; Erin Higginbotham; Erik Green; Alan Maisel
Journal:  J Cardiovasc Transl Res       Date:  2013-04-20       Impact factor: 4.132

Review 7.  Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Authors:  Jun R Chiong; Geoffrey T Jao; Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

8.  Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.

Authors:  Sayma Sabrina Khanam; Jung-Woo Son; Jun-Won Lee; Young Jin Youn; Junghan Yoon; Seung-Hwan Lee; Jang-Young Kim; Sung Gyun Ahn; Min-Soo Ahn; Byung-Su Yoo
Journal:  BMC Cardiovasc Disord       Date:  2017-08-03       Impact factor: 2.298

Review 9.  B-type natriuretic peptide and its role in altering Ca2+-regulatory proteins in heart failure-mechanistic insights.

Authors:  Jiaqi Zhao; Tongda Xu; Yao Zhou; You Zhou; Yong Xia; Dongye Li
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

Review 10.  Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.

Authors:  Michael A Burke; William G Cotts
Journal:  Heart Fail Rev       Date:  2007-03-08       Impact factor: 4.654

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.